These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 20376044)
21. Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: the PRISMS study. Oger J; Francis G; Chang P; J Neurol Sci; 2005 Oct; 237(1-2):45-52. PubMed ID: 16026803 [TBL] [Abstract][Full Text] [Related]
22. Combination therapy for treatment of multiple sclerosis. Lublin FD; Reingold SC Ann Neurol; 1998 Jul; 44(1):7-9. PubMed ID: 9667587 [No Abstract] [Full Text] [Related]
23. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis. Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418 [TBL] [Abstract][Full Text] [Related]
24. [Advances in the therapy of multiple sclerosis with interferon beta-1a]. Nervenarzt; 1997 Oct; 68(10 Suppl):1-8. PubMed ID: 9375645 [No Abstract] [Full Text] [Related]
25. Targets for the therapeutic action of interferon-beta in multiple sclerosis. Hartung HP; Kieseier BC Ann Neurol; 1996 Dec; 40(6):825-6. PubMed ID: 9007085 [No Abstract] [Full Text] [Related]
26. The use of interferon beta at the time of initial diagnosis of multiple sclerosis. Pender MP J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589 [No Abstract] [Full Text] [Related]
27. [Interferon beta-1b in multiple sclerosis. Basic therapy in intermittent and secondary progressive course]. Nervenarzt; 1999 Nov; 70(11 Suppl Basisthera):1-4. PubMed ID: 10603601 [No Abstract] [Full Text] [Related]
28. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? Hodgkinson SJ J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587 [No Abstract] [Full Text] [Related]
29. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against. Macdonell R J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588 [No Abstract] [Full Text] [Related]
30. [Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies]. Ouallet JC Rev Neurol (Paris); 2010 Jan; 166(1):21-31. PubMed ID: 19596382 [TBL] [Abstract][Full Text] [Related]
31. The impact of interferon-beta treatment on the blood-brain barrier. Kraus J; Oschmann P Drug Discov Today; 2006 Aug; 11(15-16):755-62. PubMed ID: 16846804 [TBL] [Abstract][Full Text] [Related]